Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Omega Therapeutics (OMGA)
NASDAQ:OMGA
Holding OMGA?
Track your performance easily
OMGA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.89 - $6.30
Previous Close$1.09
Volume291.57K
Average Volume (3M)239.78K
Market Cap
$60.12M
Enterprise Value$141.12M
Total Cash (Recent Filing)$45.90M
Total Debt (Recent Filing)$126.90M
Price to Earnings (P/E)―
Beta1.97
Next Earnings
Mar 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.43
Shares Outstanding55,154,985
10 Day Avg. Volume246,209
30 Day Avg. Volume239,776
Standard Deviation0.31
R-Squared0.09
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)2.27
Price to Sales (P/S)9.52
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue29.94
Enterprise Value/Gross Profit45.61
Enterprise Value/Ebitda-1.67
Forecast
1Y Price Target
$12.00Price Target Upside952.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Omega Therapeutics News
PremiumCompany Announcements
Omega Therapeutics Welcomes Robert Rosiello to Board
PremiumCompany Announcements
Omega Therapeutics Appoints New Chief Business OfficerOwnership Overview
1.55%
Insiders
9.13% Mutual Funds
1.34% Other Institutional Investors
85.90% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OMGA FAQ
What was Omega Therapeutics’s price range in the past 12 months?
Omega Therapeutics lowest stock price was $0.89 and its highest was $6.30 in the past 12 months.
What is Omega Therapeutics’s market cap?
Currently, no data Available
When is Omega Therapeutics’s upcoming earnings report date?
Omega Therapeutics’s upcoming earnings report date is Mar 06, 2025 which is in 113 days.
How were Omega Therapeutics’s earnings last quarter?
Currently, no data Available
Is Omega Therapeutics overvalued?
According to Wall Street analysts Omega Therapeutics’s price is currently Undervalued.
Does Omega Therapeutics pay dividends?
Omega Therapeutics does not currently pay dividends.
What is Omega Therapeutics’s EPS estimate?
Omega Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Omega Therapeutics have?
Omega Therapeutics has 55,154,984 shares outstanding.
What happened to Omega Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Omega Therapeutics?
Among the largest hedge funds holding Omega Therapeutics’s share is Flagship Pioneering Inc.. It holds Omega Therapeutics’s shares valued at 60M.
---
Omega Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.00 (952.63% Upside)
$12.00 (952.63% Upside)
Blogger Sentiment
Bullish
OMGA Sentiment 100%
Sector Average 73%
Sector Average 73%
Hedge Fund Trend
Decreased
By 540.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.62%
12-Months-Change
Fundamentals
Return on Equity
-129.15%
Trailing 12-Months
Asset Growth
-26.55%
Trailing 12-Months
Company Description
Omega Therapeutics
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using the epigenomic controllers, Omega is seeking to transform the practice of human medicine through highly selective and direct control of the human genome to treat and cure disease.
---
OMGA Stock 12 Month Forecast
Average Price Target
$12.00
▲(952.63% Upside)
Technical Analysis
Caribou Biosciences
―
Prime Medicine, Inc.
―
Intellia Therapeutics
―
Beam Therapeutics
―
Best Analysts Covering OMGA
1 Year
1 Year Success Rate
2/8 ratings generated profit
1 Year Average Return
-7.19%
reiterated a buy rating 7 months ago
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -7.19% per trade.
---